[1]
Cristiani, M. et al. 2010. Economic evaluation of the use of saxagliptin in the treatment of type 2 diabetes in Italy. Farmeconomia. Health economics and therapeutic pathways. 11, 2 (Jun. 2010), 103–115. DOI:https://doi.org/10.7175/fe.v11i2.182.